Yearly Archives: 2002


Infomail Archive – Pre 2003 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav December 28, 2002: Will 2 to 5 year old Amer. kids be exposed to Smallpox Vaccine? Israeli Intelligence says “No immediate threat” December 24, 2002: Moral turpitude: Herpes experiment surpasses Tuskegee December 20, […]

Infomail Archive



FDA approves anti-psychotic, clozapine, to treat suicide December 20, 2002 The first of the so-called atypical antipsychotic drugs, clozapine (Clozaril), has been approved by the FDA as a treatment against suicide in patients with schizophrenia. The drug has been hailed as a miracle for some, but deadly for others. The […]

FDA approves anti-psychotic, clozapine, to treat suicide





Ethics Questioned in Lung Disease Trial–Feds Demand Patient Data – Newhouse News December 13, 2002 A news breaking story by Bruce Seeman of Newhouse News (excerpts below) reveals a major systemic breakdown in medical ethics–“there’s something rotten in the state of [biomedical research].” Complaints about a lung disease air ventilation […]

Ethics Questioned in Lung Disease Trial–Feds Demand Patient Data – ...



Patient vs. Portfolio: ImClone_Salon December 10, 2002. Salon.com looks at how conflicts of interest impact on patients who are recruited to serve as subjects of clinical drug trials. “Patients affected by the ImClone scandal have been lost in the media’s rush to cover the tale of Martha Stewart and other […]

Patient vs. Portfolio: ImClone_Salon


Patient vs. Portfolio: ImClone_Salon December 9, 2002 Salon.com looks at how conflicts of interest impact on patients who are recruited to serve as subjects of clinical drug trials. “Patients affected by the ImClone scandal have been lost in the media’s rush to cover the tale of Martha Stewart and other […]

Patient vs. Portfolio: ImClone – Salon


THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Tel. 212-595-8974             142 West End Ave Suite 28P                     FAX: 212-595-9086 New York, NY 10023 www.ahrp.org December 5, 2002 Mr. Edward Swindell Acting Associate General Counsel for Ethics Office of General Counsel, Ethics Division Department of Health and Human Services 200 Independence […]

Article



Recent public and professional debate about smallpox vaccine and its risks provides the framework for evaluating the ethical justification for conducting clinical trials on children. Dryvax is a particularly impure product made of live vaccinia virus harvested from the pustules of calves infected with (it is believed) cowpox. Although the vaccine, which is scratched on the skin, only causes mild infections in most people, in a small but significant number the infection caused serious adverse reactions similar to the complications of the disease they were designed to prevent: painful, disfiguring skin disorders, blindness, neurological impairments and death.

AHRP Comments on Smallpox Vaccine Testing on Children 2 to ...